Clinical Trial

Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.

Study acronym: BREFORM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
In psychiatry, caregiver burden is associated with excess physical and psychological morbidity in relatives of patients with schizophrenic disorders Single or multi-family psychoeducation for caregivers of patients with schizophrenic disorders or first episode psychosis has a direct benefit on the health of the caregiver and an indirect benefit on the health of the ill family member. It is associated with a reduction in the rate of relapse and re-hospitalization and with better compliance with treatment. For single-family psychoeducation, the number of caregivers to be treated to avoid re-hospitalization of the sick family member is 3. For caregivers, psychoeducation is accompanied by an improvement in knowledge of the disorders and coping strategies. Therefore, international recommendations recommend that psychoeducation for caregivers be systematic, early, and integrated into routine care. Currently, the organization of the French care system does not allow these recommendations to be met. In order to increase the use of psychoeducation in France, early interventions for caregivers must be offered systematically. The effectiveness of early psychoeducation for caregivers needs to be evaluated; only three randomized controlled trials are available in the literature and none have been conducted in France.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-08-31; most recent amendment 2026-06-10.
Status change: Not Yet Recruiting → Recruiting 2022-08-11
Trial Details
NCT Number NCT05036590
Lead Sponsor Hôpital le Vinatier
Conditions Schizophrenia
Enrollment 206 participants
Start Date 2022-04-05
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-12